Dataset Open Access
P. I. Koukos;
M. Réau;
A. M. J. J. Bonvin
{ "files": [ { "links": { "self": "https://zenodo.org/api/files/888dd461-d468-4a09-a177-852a12516822/mpro_pharmacophore.tar.xz" }, "checksum": "md5:307f4ce285e402fa7788cf26ab260535", "bucket": "888dd461-d468-4a09-a177-852a12516822", "key": "mpro_pharmacophore.tar.xz", "type": "xz", "size": 10730281688 } ], "owners": [ 109022 ], "doi": "10.5281/zenodo.3929446", "stats": { "version_unique_downloads": 14.0, "unique_views": 454.0, "views": 497.0, "version_views": 497.0, "unique_downloads": 14.0, "version_unique_views": 454.0, "volume": 150223943632.0, "version_downloads": 14.0, "downloads": 14.0, "version_volume": 150223943632.0 }, "links": { "doi": "https://doi.org/10.5281/zenodo.3929446", "conceptdoi": "https://doi.org/10.5281/zenodo.3929445", "bucket": "https://zenodo.org/api/files/888dd461-d468-4a09-a177-852a12516822", "conceptbadge": "https://zenodo.org/badge/doi/10.5281/zenodo.3929445.svg", "html": "https://zenodo.org/record/3929446", "latest_html": "https://zenodo.org/record/3929446", "badge": "https://zenodo.org/badge/doi/10.5281/zenodo.3929446.svg", "latest": "https://zenodo.org/api/records/3929446" }, "conceptdoi": "10.5281/zenodo.3929445", "created": "2020-07-03T13:16:18.283398+00:00", "updated": "2020-07-06T07:29:51.313305+00:00", "conceptrecid": "3929445", "revision": 7, "id": 3929446, "metadata": { "access_right_category": "success", "doi": "10.5281/zenodo.3929446", "version": "1.0.0", "language": "eng", "title": "HADDOCK pharmacophore-based screening against the COVID-19 main protease (Mpro)", "license": { "id": "CC0-1.0" }, "related_identifiers": [ { "scheme": "doi", "identifier": "10.5281/zenodo.3929445", "relation": "isVersionOf" } ], "relations": { "version": [ { "count": 1, "index": 0, "parent": { "pid_type": "recid", "pid_value": "3929445" }, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "3929446" } } ] }, "communities": [ { "id": "bioexcel" }, { "id": "covid-19" }, { "id": "covid19-structure-hub" }, { "id": "zenodo" } ], "grants": [ { "code": "823830", "links": { "self": "https://zenodo.org/api/grants/10.13039/501100000780::823830" }, "title": "BioExcel-2 Centre of Excellence for Computational Biomolecular Research", "acronym": "BioExcel-2", "program": "H2020", "funder": { "doi": "10.13039/501100000780", "acronyms": [], "name": "European Commission", "links": { "self": "https://zenodo.org/api/funders/10.13039/501100000780" } } }, { "code": "777536", "links": { "self": "https://zenodo.org/api/grants/10.13039/501100000780::777536" }, "title": "Integrating and managing services for the European Open Science Cloud", "acronym": "EOSC-hub", "program": "H2020", "funder": { "doi": "10.13039/501100000780", "acronyms": [], "name": "European Commission", "links": { "self": "https://zenodo.org/api/funders/10.13039/501100000780" } } } ], "keywords": [ "Docking", "Virtual Screening", "HADDOCK", "COVID-19" ], "publication_date": "2020-07-03", "creators": [ { "affiliation": "Utrecht University", "name": "P. I. Koukos" }, { "orcid": "0000-0002-3862-8990", "affiliation": "Utrecht University", "name": "M. R\u00e9au" }, { "orcid": "0000-0001-7369-1322", "affiliation": "Utrecht University", "name": "A. M. J. J. Bonvin" } ], "access_right": "open", "resource_type": { "type": "dataset", "title": "Dataset" }, "description": "<p>The novel coronavirus (SARS-CoV-2) that has emerged from Wuhan, China in December 2019 has spread to almost all countries in the world causing a dramatic number of deaths. The current absence of antiviral treatment against the SARS-CoV-2 urges the scientific community to accelerate the drug discovery research process.</p>\n\n<p>One way to identify potential treatments and to be able to administer it swiftly is to focus on drug repurposing studies, i.e. to investigate the SARS-CoV-2 antiviral potential of drugs that have already been approved for human use.</p>\n\n<p>Proteins that are crucial for the survival and replication of the virus are the most attractive targets for such studies. Here we have focused on the SARS-CoV-2 main protease (3CLpro) that plays an essential role in the virus replication process by screening ~2000 approved drugs (and 6 experimental ones) against this particular protein using a pharmacophore-based assay.</p>\n\n<p>This is one part of a multi-target screen emphasising the main protease (Mrpo), the RNA-dependent-RNA-polymerase (RdRp) and human ACE2. The other datasets can found at the following locations:</p>\n\n<ul>\n\t<li><a href=\"https://zenodo.org/record/3929438\">Mpro: Shape-based assay</a></li>\n\t<li><a href=\"https://zenodo.org/record/3929463\">ACE2</a></li>\n\t<li><a href=\"https://zenodo.org/record/3929449\">RdRp</a></li>\n</ul>\n\n<p>More information about this screen along with interactive visualisations of the top compounds can be found on our website <a href=\"https://bonvinlab.org/covid/\">bonvinlab.org</a>.</p>" } }
All versions | This version | |
---|---|---|
Views | 497 | 497 |
Downloads | 14 | 14 |
Data volume | 150.2 GB | 150.2 GB |
Unique views | 454 | 454 |
Unique downloads | 14 | 14 |